Showing 1 - 10 of 483
Da der Pharmasektor eine der forschungsintensivsten Branchen weltweit ist, können Übernahmen erhebliche negative wie positive Auswirkungen auf Innovationen haben. In diesem Wochenbericht werden auf Basis von internationalen Unternehmensdaten der Jahre 1997 bis 2017 Übernahmen in der...
Persistent link: https://www.econbiz.de/10015070046
This paper analyzes M&A patterns of R&D projects in the antidiabetics industry. For this purpose, we construct a database with all corporate individual antidiabetics R&D projects over the period 1997 - 2017, and add detailed information on firms' technology dimension using patent information,...
Persistent link: https://www.econbiz.de/10014468769
Persistent link: https://www.econbiz.de/10014469053
This paper analyzes M&A patterns of R&D projects in the antidiabetics industry. For this purpose, we construct a database with all corporate individual antidiabetics R&D projects over the period 1997 - 2017, and add detailed information on firms’ technology dimension using patent information,...
Persistent link: https://www.econbiz.de/10014473094
Die Bereitstellung eines sicheren und wirksamen Impfstoffs gegen Covid-19 ist von zentraler Bedeutung für die Aufhebung der Eindämmungsmaßnahmen im öffentlichen Leben. Um den Zugang zu Impfstoffen zu sichern, schließen Regierungen mit Impfstoffunternehmen spezielle Verträge, "Advance...
Persistent link: https://www.econbiz.de/10012285331
The deployment of a safe and effective vaccine for Covid-19 will be central to lifting containment measures. In a bid to speed up vaccine deployment, governments are entering into ‘Advance Purchase Agreements’ (APAs) with vaccine companies to secure access to vaccine doses. We document and...
Persistent link: https://www.econbiz.de/10012404422
This paper provides empirical evidence on which M&A deals spur innovation, and which stifle it. To do so, we consider not only the product market position of the acquiring firm, but also the position of both target and acquirer in the technology space. Focusing on the antidiabetic drugs market,...
Persistent link: https://www.econbiz.de/10015434666
Persistent link: https://www.econbiz.de/10015435938
We investigate patterns in common ownership networks between firms that are active in the US pharmaceutical industry for the period 2004-2014. Our main findings are that “brand firms” — i.e. firms that have R&D capabilities and launch new drugs — exhibit relatively dense common ownership...
Persistent link: https://www.econbiz.de/10013237668
Common ownership - where two firms are at least partially owned by the same investor - and its impact on product market outcomes has recently drawn a lot of attention from scholars and practitioners alike. Theoretical and empirical researchsuggests that common ownership can lead to higher...
Persistent link: https://www.econbiz.de/10012899061